ConductScience.org, home

Trial · NCT02468674

Results by group45

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I: BYM338 700 mg8.8Standard Deviation 3.86Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I BYM338: 700 mg to Placebo10.2Standard Deviation 1.92Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I: BYM338 210 mg8.0Standard Deviation 2.35Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I BYM338: 210 mg to Placebo8.0Standard Deviation 2.65Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I: BYM338 70 mg9.5Standard Deviation 2.17Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I: BYM338 70 mg to Placebo7.5Standard Deviation 3.78Scores on a scale
Population I: Short Physical Performance Battery (SPPB) Total Score at Week 49Population I: Placebo9.6Standard Deviation 1.83Scores on a scale
Population II: Short Physical Performance Battery (SPPB) Total Score at Week 49Population: II BYM338 700 mg8.6Standard Deviation 2.40Scores on a scale
Population II: Short Physical Performance Battery (SPPB) Total Score at Week 49Population: II Placebo8.8Standard Deviation 1.55Scores on a scale
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I: BYM338 700 mg318.2Standard Deviation 159.55meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I BYM338: 700 mg to Placebo354.1Standard Deviation 69.98meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I: BYM338 210 mg304.1Standard Deviation 63.05meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I BYM338: 210 mg to Placebo361.5Standard Deviation 144.53meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I: BYM338 70 mg316.1Standard Deviation 97.87meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I: BYM338 70 mg to Placebo273.4Standard Deviation 154.03meters
Population I: 6-minute Walking Distance (6MWT) at Week 49Population I: Placebo368.7Standard Deviation 108.37meters
Population II: 6-minute Walking Distance (6MWT) at Week 49Population: II BYM338 700 mg321.2Standard Deviation 105.13meters
Population II: 6-minute Walking Distance (6MWT) at Week 49Population: II Placebo323.1Standard Deviation 96.47meters
Population I: Gait Speed at Week 49Population I: BYM338 700 mg0.8Standard Deviation 0.35m/sec
Population I: Gait Speed at Week 49Population I BYM338: 700 mg to Placebo1.0Standard Deviation 0.18m/sec

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02468674/results